Related Experiment Videos
Suspicious skin lesions and their management
1North Queensland Clinical School, University of Queensland.
Australian Family Physician
|June 22, 1999
Summary
General practitioners encounter various suspicious skin lesions, with many being benign and not requiring excision. When basal cell carcinoma (BCC) or squamous cell carcinoma (SCC) is suspected, lesions are typically biopsied or excised.
Area of Science:
- Dermatology
- General Practice
- Oncology
Background:
- Suspicious skin lesions are a common presentation in general practice.
- Accurate diagnosis and management are crucial for patient outcomes and preventing skin cancer progression.
Purpose of the Study:
- To characterize the range of non-pigmented suspicious skin lesions seen in general practice.
- To evaluate the diagnostic accuracy and management strategies employed by general practitioners for these lesions.
Main Methods:
- General practitioners (GPs) in Queensland, Australia, prospectively recorded data on suspicious skin lesions over six weeks.
- Data included lesion type, clinical diagnosis, and management decisions (biopsy, excision, treatment without biopsy, referral, monitoring).
- Diagnostic accuracy for malignant lesions was calculated, and management options were compared based on diagnostic certainty.
Main Results:
- 1355 lesions were recorded, including non-melanoma skin cancers (28.6%), dysplastic lesions (61.7%), and benign lesions (9.7%).
- Clinical diagnosis of malignancy was correct in 69.1% of histologically confirmed basal cell carcinoma (BCC) or squamous cell carcinoma (SCC) cases.
- Management varied, with excision or biopsy being common for suspected BCC/SCC, while solar keratoses were often treated without biopsy if the diagnosis was certain.
Conclusions:
- General practitioners manage a diverse array of suspicious skin lesions, many of which are benign.
- A significant proportion of concerning lesions are managed conservatively without biopsy.
- Excision or biopsy is the preferred management for suspected basal cell carcinoma or squamous cell carcinoma, or when the diagnosis is uncertain.